BPIFA2 Antikörper (AA 151-249)
Kurzübersicht für BPIFA2 Antikörper (AA 151-249) (ABIN2171168)
Target
Alle BPIFA2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 151-249
-
Homologie
- Human
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human C20orf70
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- BPIFA2 (BPI Fold Containing Family A, Member 2 (BPIFA2))
-
Andere Bezeichnung
- C20orf70
-
Hintergrund
-
Synonyms: bA49G10.1, chromosome 20 open reading frame 70, lung and nasal epithelium carcinoma-associated protein 2, Neonatal submandibular gland protein, Parotid secretory protein, PSP, Short palate, short palate lung and nasal epithelium carcinoma associated 2, short palate, lung and nasal epithelium carcinoma associated protein 2, SPLC2_HUMAN, SPLUNC2.
Background: C20orf70
Target
-